iRhythm Technologies is a new company to enter the field of Holter monitoring. Located in San Francisco, iRhythm Technologies has a unique approach to Holter monitoring as their form of continuous monitoring is in the form of a wearable ‘peel & stick’ patch called the Zio™ Patch. The Zio™ Patch is a generally worn for an extended period of time ranging from 7-14 days.
iRhythm Continuous ECG Monitoring Technology
iRhythm has pioneered the ambulatory cardiac monitoring segment with their ZIO Patch wearable monitoring. This has proven to be a distinct competitive advantage as a cardiac monitoring option as the compliance is far superior to any other form of cardiac monitoring. The ZIO Patch is proven to be unique in design and preferred by more patients than any other monitoring modality. Further, iRhythm has enjoyed great success in raising nearly $85million dollars for the advancement of the Zio Patch continuous ECG monitoring technology.
Clinical Findings of ZIO® Patch
iRhythm has performed various clinical trials that indicate that a longer continuous monitor is superior to detecting various various cardiac arrhythmias versus the standard 24 hour monitoring period. For example, iRhythm conducted a study that demonstrates that the ZIO Patch detected 57% more arrhythmias than a standard 24-48 hour Holter monitor study.
A second study demonstrated that the ZIO Patch detects far more arrhythmias if worn for a period greater than an extended 48 hour Holter monitor. The ZIO Patch found:
- 51% of the patients did not have their first symptom triggered arrhythmia
- 47% of patients experienced Atrial Fibrillation
- 30% patients experience their first documented arrhythmia of any kind
iRhythm is demonstrating the use of their ZIO Patch to be a superior method of detecting asymptomatic Atrial Fibrillation (A Fib). As many in the industry know, detection of A Fib is a evolving to be a significant advancement in the prevention and managment of Transient Ischemic Attack (TIA) or stroke. Many experts believe that the ZIO Patch is a useful tool for early detection of Atrial Fibrillation in cases where this abnormal rhythm may go undetected with other forms of cardiac monitoring such as Holter monitoring.
iRhythm Technologies is a Medicare approved Independent Diagnostic Testing Facility (IDTF) at both of their laboratories located in San Francisco, CA and Linconshire, IL The iRhythm ZIO Patch received its FDA approval in 2009.